Aurobindo Pharma submits ANDA for Adapalene and Benzoyl Peroxide
Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for a combination of Adapalene and Benzoyl Peroxide.
Therapeutic Area
Therapeutic area intelligence for Acne with 9 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.